TSX:BHC (Bausch Health Companies Inc.)
About BHC
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Bausch Health Companies Inc. (TSX: BHC) Latest News
Investing
Valeant Pharmaceuticals Intl Inc. Crushed by Citron Research: Find Out Who’s Next
Investing
Will These Companies Be Back in Vogue in 2017?
Investing
Checklist: How to Find a Great Stock
Investing
Valeant Pharmaceuticals Intl Inc.: Should You Take a Contrarian Shot?
Investing
Why I’m Avoiding Valeant Pharmaceutical Intl Inc. Like the Plague
Investing
Will Valeant Pharmaceuticals Intl Inc. Survive the Trump Presidency?
Investing
How 2017 Will Unfold for Valeant Pharmaceuticals Intl Inc.
Investing
Explaining the Interest Costs of Valeant Pharmaceuticals Intl Inc.
Investing
Simple Math Doesn’t Work at Valeant Pharmaceuticals Intl Inc.
Tech Stocks
Valeant Pharmaceuticals Intl Inc. on Fire to Start the Year
Investing
On the Move! Valeant Pharmaceuticals Intl Inc. Rises Again